These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 33633048)
1. Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty. Di Filippo C; Caniato F; Cappelli F; Mattesini A; Meucci F; Sori A; Stolcova M; Agostini C; Bernardo P; Di Mario C J Cardiovasc Med (Hagerstown); 2021 Apr; 22(4):317-319. PubMed ID: 33633048 [No Abstract] [Full Text] [Related]
2. Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Franchi F; Rollini F; Rivas A; Wali M; Briceno M; Agarwal M; Shaikh Z; Nawaz A; Silva G; Been L; Smairat R; Kaufman M; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ Circulation; 2019 Apr; 139(14):1661-1670. PubMed ID: 30630341 [TBL] [Abstract][Full Text] [Related]
3. Intracoronary cangrelor administration-assisted primary percutaneous coronary intervention in a patient with essential thrombocythemia and recurrent ST-segment elevation myocardial infarction. Ielasi A; Loffi M; Buono A; De Blasio G; Tespili M J Cardiovasc Med (Hagerstown); 2020 Oct; 21(10):825-828. PubMed ID: 32740411 [No Abstract] [Full Text] [Related]
4. de Winter syndrome or inferior STEMI? Wang S; Shen L BMC Cardiovasc Disord; 2021 Dec; 21(1):614. PubMed ID: 34961517 [TBL] [Abstract][Full Text] [Related]
5. Randomized Comparison of Oral P2Y Hochholzer W; Kleiner P; Younas I; Valina CM; Löffelhardt N; Amann M; Bömicke T; Ferenc M; Hauschke D; Trenk D; Neumann FJ; Stratz C JACC Cardiovasc Interv; 2017 Jan; 10(2):121-129. PubMed ID: 28104204 [TBL] [Abstract][Full Text] [Related]
6. Clinical use of cangrelor: nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Grimfjärd P; Lagerqvist B; Erlinge D; Varenhorst C; James S Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):151-157. PubMed ID: 30698669 [TBL] [Abstract][Full Text] [Related]
7. Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial. Gargiulo G; Esposito G; Avvedimento M; Nagler M; Minuz P; Campo G; Gragnano F; Manavifar N; Piccolo R; Tebaldi M; Cirillo P; Hunziker L; Vranckx P; Leonardi S; Heg D; Windecker S; Valgimigli M Circulation; 2020 Aug; 142(5):441-454. PubMed ID: 32795098 [TBL] [Abstract][Full Text] [Related]
8. Cangrelor in Percutaneous Coronary Intervention: Current Status and Perspectives. Alexopoulos D; Pappas C; Sfantou D; Lekakis J J Cardiovasc Pharmacol Ther; 2018 Jan; 23(1):13-22. PubMed ID: 29228817 [TBL] [Abstract][Full Text] [Related]
9. Optimal platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention. Fiore M; Gerbaud E; Coste P; Cetran L; Marchand H; Seguy B Resuscitation; 2018 Sep; 130():e1-e2. PubMed ID: 29969644 [No Abstract] [Full Text] [Related]
10. Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus. Sardella G; Mancone M; Stio RE; Cavallo E; Di Roma A; Colantonio R; Calcagno S Circulation; 2017 Aug; 136(6):602-604. PubMed ID: 28784829 [No Abstract] [Full Text] [Related]
12. A reversible cause of hypoxaemia in a patient with acute right ventricular infarction. Makavos G; Cholevas NV; Rallidis LS Hellenic J Cardiol; 2019; 60(4):258-260. PubMed ID: 30448622 [No Abstract] [Full Text] [Related]
13. The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX. Gutierrez JA; Harrington RA; Blankenship JC; Stone GW; Steg PG; Gibson CM; Hamm CW; Price MJ; Généreux P; Prats J; Deliargyris EN; Mahaffey KW; White HD; Bhatt DL; Eur Heart J; 2016 Apr; 37(14):1122-30. PubMed ID: 26400827 [TBL] [Abstract][Full Text] [Related]
14. Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series. Bowman S; Gass J; Weeks P Ann Pharmacother; 2019 Feb; 53(2):171-177. PubMed ID: 30132336 [TBL] [Abstract][Full Text] [Related]